About: Andrew Pecora

An Entity of Type: medician, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Andrew Louis Pecora (born 1957) is an American hematologist and oncologist involved in research on the use of stem cells and oncolytic viruses to treat diseases, including cancer. He is the CEO of Outcomes Matter Innovations. As of 2020, he is on the Board of Directors Celularity, Inc. (since 2017) and founder and Executive Chairman, COTA, Inc. (since 2012). Previously, he was chief innovations officer, professor and vice president of cancer services at the John Theurer Cancer Center, part of the Hackensack University Medical Center. He is a professor of medicine and oncology at Georgetown University.

Property Value
dbo:abstract
  • Andrew Louis Pecora (born 1957) is an American hematologist and oncologist involved in research on the use of stem cells and oncolytic viruses to treat diseases, including cancer. He is the CEO of Outcomes Matter Innovations. As of 2020, he is on the Board of Directors Celularity, Inc. (since 2017) and founder and Executive Chairman, COTA, Inc. (since 2012). Previously, he was chief innovations officer, professor and vice president of cancer services at the John Theurer Cancer Center, part of the Hackensack University Medical Center. He is a professor of medicine and oncology at Georgetown University. (en)
dbo:birthName
  • Andrew Louis Pecora (en)
dbo:birthPlace
dbo:education
dbo:institution
dbo:occupation
dbo:profession
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 53649838 (xsd:integer)
dbo:wikiPageLength
  • 18629 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1122313536 (xsd:integer)
dbo:wikiPageWikiLink
dbp:birthName
  • Andrew Louis Pecora (en)
dbp:birthPlace
dbp:education
dbp:field
dbp:honorificSuffix
dbp:name
  • Andrew Pecora (en)
dbp:nationality
  • American (en)
dbp:occupation
dbp:profession
dbp:text
  • This report of 79 patients is lengthy and complicated, but by necessity rather than by choice. Whether or not this agent proves effective against cancer, this phase I trial merits careful study, because viral therapies for cancer are emerging, and their optimal development is a major challenge. (en)
dbp:wikiPageUsesTemplate
dbp:workInstitutions
dcterms:subject
rdf:type
rdfs:comment
  • Andrew Louis Pecora (born 1957) is an American hematologist and oncologist involved in research on the use of stem cells and oncolytic viruses to treat diseases, including cancer. He is the CEO of Outcomes Matter Innovations. As of 2020, he is on the Board of Directors Celularity, Inc. (since 2017) and founder and Executive Chairman, COTA, Inc. (since 2012). Previously, he was chief innovations officer, professor and vice president of cancer services at the John Theurer Cancer Center, part of the Hackensack University Medical Center. He is a professor of medicine and oncology at Georgetown University. (en)
rdfs:label
  • Andrew Pecora (en)
owl:sameAs
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Andrew Pecora (en)
is dbo:wikiPageDisambiguates of
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License